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Selection of v-Abl Tyrosine Kinase Substrate
Sequences from Randomized Peptide and Cellular
Proteomic Libraries Using mRNA Display
hybrid and its derivatives) [6–8] or following cell surface
expression (phage and Eschericia coli display) [9–12].
Although these systems are capable of detecting protein-
protein interactions, their ability to identify proteins tar-
geted for posttranslational modification has not been dem-
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onstrated. Numerous in vitro protein display systems have
also been developed [13, 14]; however, in most cases,
the absence of a robust linkage between genotype andSummary
phenotype limits their applicability in studying enzy-
matic modifications. Although methodologies for theMethodologies for rapidly identifying cellular protein
identification of kinase substrates has generally laggedinteractions resulting in posttranslational modification
behind those aimed at elucidating protein-protein inter-of one of the partners are lacking. Here, we select
actions, several approaches have been employed.for substrates of the v-abl tyrosine kinase from two
These include phosphorylation of proteins immobilizedprotein display libraries in which the protein is cova-
on a nitrocellulose filter, following induction of a phagelently linked to its encoding mRNA. Successive selec-
expression library [15]; mutation of the kinase’s ATPtion cycles from a randomized peptide library identi-
binding site, allowing it to accept N6 -modified ATP ana-fied a consensus sequence closely matching that
logs that can be used as substrate tags [16]; and thepreviously reported for the v-abl tyrosine kinase. Se-
selection of phosphorylated targets from synthetic pep-lections from a proteomic library derived from cellular
tide libraries [17]. In this latter approach, a random pep-mRNA identified several novel targets of v-abl, includ-
tide library is phosphorylated in vitro by the kinase ofing a new member of a class of SH2 domain-containing
interest, the substrates are recovered on a metal-chelat-adaptor proteins. Upon modification, several of the
ing column, and the mixture of proteins is sequenced.substrates obtained in these selections were found to
mRNA-protein fusion libraries (mRNA display), inbe effective inhibitors of v-abl kinase activity in vitro.
which proteins are linked to their encoding mRNA via theThese experiments establish a novel method for identi-
O-methyl tyrosine portion of puromycin, offer a powerfulfying the substrates of tyrosine kinases from synthetic
approach to screening large protein libraries. In thisand cellular protein libraries.
system, rabbit reticulocyte lysates are used to produce
proteins in vitro and covalently attach them to their en-
Introduction coding mRNA. Because the link between the protein
and its genotype is covalent, the protein moiety can be
Phosphorylation of proteins on their serine, threonine, selected under robust conditions and its genetic mate-
and tyrosine residues is one of the most commonly oc- rial can be amplified by PCR in an entirely in vitro system
curring posttranslational modifications in eukaryotic [18, 19]. Repeated rounds of selection from a library
cells. Cellular phosphorylation cascades allow for the of mRNA-protein fusion molecules allows for the rapid
amplification of extracellular signals following changes enrichment of proteins having a desired phenotype.
in environmental conditions via the ability of phosphory- Since library synthesis and selection occurs entirely in
lated activators to modulate the expression of numerous vitro, it is possible to minimize the loss of genetic infor-
genes. Because these reactions are rapidly reversible, mation normally associated with the subcloning and
they are important for the regulation of many cellular transformation steps of in vivo protein display systems
functions including signal transduction, cell division, (see [20] for a review). Recently, “mRNA display” has
and proliferation. The specificity of these interactions is been used to select for high-affinity streptavidin binding
determined by a number of parameters, including cellu- aptamers (5 nM) from a nonconstrained peptide library
lar colocalization of the enzyme and its substrate, sec- [21]. The in vitro nature of the mRNA-protein selection
ondary interactions between the enzyme and the sub- technique makes it ideally suited for the identification
strate, as well as the substrate specificity of the kinase of protein target sequences undergoing specific post-
catalytic domain [1–3]. Identification of kinase substrate translational modifications and allows a variety of differ-
sequences is a critical step toward understanding the ent selection conditions to be examined. Here, we de-
biology of these kinases and provides an important scribe the identification of optimal target sequences for
venue for the development of kinase inhibitory reagents. the v-abl tyrosine kinase from a random peptide library
Numerous in vivo and in vitro protein display technolo- as well as from a proteomic library derived from the
gies have developed in an attempt to decipher the myr- mRNA of human bone marrow cells.
iad of biological pathways that occur in a cell [4, 5]. The nonreceptor tyrosine kinase v-abl is encoded by
Strategies involving in vivo display of protein domains the Abelson murine leukemia virus and is a potent onco-
generally involve making proteomic libraries derived gene in mice. The closely related human proto-onco-
from cellular mRNA and then selecting for desired inter- gene c-abl contains the src-homology (SH) regions 1,
actions either within the organism itself (yeast two- 2, and 3, which confer phosphorylation activity (SH1),
ability to bind phosphorylated tyrosines (SH2), and ki-
nase inhibitory functions (SH3) to the protein [22, 23]. A1Correspondence: tcujec@phylos.com
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reciprocal translocation between c-abl (chromosome 9) in which an invariant tyrosine was flanked by five ran-
domized amino acids (GCGGX5-Y-X5GCG). In addition,and the bcr gene (chromosome 22) results in the potent
oncogene BCR-abl, which is implicated in the pathogen- the fixed flanking regions contained two cysteine resi-
dues to provide the opportunity for the random region toesis of 95% of chronic myelogenous leukemias and 10%
of acute lymphocytic leukemias [24, 25]. Although nu- be presented as a constrained loop. The mRNA-peptide
fusions were phosphorylated by v-abl in vitro, immuno-merous putative substrates of the abl kinases have been
identified, including those involved in cell architecture, precipitated using the phosphotyrosine-specific 4G10
antibody and the attached genetic information amplifiedtranscription, and numerous signal transduction path-
ways, the mechanism of action of these kinases remains by PCR (Figure 1).
We anticipated that the starting mRNA-peptide libraryunclear (see [23, 26, 27] for compilation). A minimal v-abl
consensus sequence (I/V/L-Y-Xn-P/F, where n  2 or 3) (25 pmol) should contain approximately one copy of
each possible sequence (2010 members). In order to mini-has been previously identified from a peptide library
randomized at eight amino acids, but the effects of larger mize the loss of genetic diversity, the starting library
was not precleared in the first round of the selection, andsequence motifs on substrate selection is unknown [28].
As a step toward understanding the abl kinase re- approximately 1.5% of the input mRNA-peptide fusion
molecules were eluted (E1  E2) from the 4G10 anti-sponse pathway, we applied a selection-based technol-
ogy to identify optimal substrate sequences of the po- body in round one (Figure 2A). In subsequent rounds,
the library was precleared by incubating it with 4G10/tent oncogene v-abl from a large randomized peptide
library (1012–1013). In addition, we identified cellular tar- protein A Sepharose beads prior to phosphorylation with
v-abl in order to remove nonspecific binders and anygets of v-abl from a proteomic mRNA-protein library
derived from the mRNA of human bone marrow cells. protein domains having tyrosines fortuitously phosphor-
ylated during the in vitro translation reaction. In roundsThe approach we describe here offers a powerful new
strategy for identifying novel substrates of tyrosine ki- two and three, the elutions did not yield detectable ra-
dioactive counts, although PCR yielded genetic materialnases and has led to the rapid identification of lead
candidates for kinase inhibitors. that was taken to the next round. In contrast, approxi-
mately 6.5% of the input mRNA-peptide fusion mole-
cules were eluted (E1  E2) from the 4G10 antibodyResults
in round four, and this increased to almost 20% in round
six. PCR analysis demonstrated that the last wash ofModel System
each round was essentially devoid of genetic materialSubstrate sequences surrounding a phosphorylated
(data not shown).residue are important in determining protein kinase
In order to confirm the enrichment of v-abl substrates,specificity. Consequently, in order to progress toward
the DNAs from the starting library and the post-rounda greater understanding of the biology of v-abl, we
six pool were expressed as free peptides and tested forsought to identify kinase substrates from a randomized
phosphorylation by v-abl (Figure 2B). No phosphoryla-peptide library and a cellular proteomic library displayed
tion of the starting peptide pool was detected, presum-as mRNA-protein fusions. In a proof of concept experi-
ably due to the low abundance of v-abl target sequencesment, a control mRNA-protein fusion molecule con-
(lane 3). In contrast, phosphorylation of the post-roundtaining an optimized v-abl phosphorylation site (EAIY
six peptide pool was readily observed (lane 4), demon-AAPFAKKK, New England Biolabs) was synthesized. Fu-
strating the enrichment of target sequences. A peptidesions were purified from the reverse transcription reac-
containing a single tyrosine residue in the FLAG epitopetion by oligo d(T) chromatography, phosphorylated with
(DYKDDDDK) was not phosphorylated by v-abl (lane 2),recombinant v-abl, and immunoprecipitated with the
demonstrating that phosphorylation of the test peptides
4G10 antibodies. Approximately 3% of the control
was sequence specific, while phosphorylation of a con-mRNA-peptide fusion molecules were immunoprecipi-
trol fusion molecule containing a known v-abl recogni-tated by the 4G10 antibody following phosphorylation
tion motif was readily detected (lane 1). Together theseby v-abl (data not shown). Immunoprecipitation was
results demonstrate that substrates of v-abl were en-specific for the phosphotyrosine antibody and abso-
riched from the mRNA-peptide library following sixlutely dependent upon recombinant v-abl. Together
rounds of selection and PCR amplification of geneticthese results demonstrated that v-abl is functional at
material.substrate concentrations (50–100 nM) significantly be-
low the Km of the enzyme (50 M) and that the transla-
tional lysates do not contain significant endogenous Sequence Analysis of the Selected Pool
v-abl activity. We reasoned, therefore, that repeated In total, 69 clones from the post-round six pool were
rounds of phosphorylation of a mRNA-protein fusion sequenced. The invariant tyrosine was missing in 2 of
library by v-abl, followed by selection of tyrosine-phos- the 69 clones. In one of these cases, a novel tyrosine
phorylated fusions with the 4G10 antibody, could be was introduced upstream of the invariant residue, while,
used to identify substrate targets of the v-abl oncogene. in the other case, there were no tyrosine residues. Of
the remaining 67 cones, 46 matched the I/L/V-Y-X1-5-P/F
consensus motif with respect to the invariant tyrosineEnrichment of mRNA-Peptide Fusions Containing
Phosphorylated Tyrosines (Figure 3A). The majority of these clones had a proline or
phenylalanine residue four (22/46) or five (23/46) aminoTo identify peptide substrates of the v-abl tyrosine ki-
nase, we synthesized an mRNA-peptide fusion library acids downstream of the invariant tyrosine.
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Figure 1. A Schematic Drawing of the Selec-
tion Procedure
In the first round of the selection, purified
mRNA-protein fusion molecules were phos-
phorylated by v-abl and subjected to immu-
noprecipitation with the 4G10 antibody. The
mRNA-protein fusion molecules were eluted
from the antibody using KOH and the cDNAs
amplified by PCR. In subsequent rounds, the
mRNA-protein pool was precleared with the
4G10/protein A Sepharose beads prior to
the kinase reaction to remove any nonspe-
cific binders, as well as mRNA-protein fu-
sions undergoing nonspecific tyrosine phos-
phorylation during in vitro translation.
In most clones (66/68), a second tyrosine was intro- phosphorylation targets. In order to identify cellular tar-
gets of v-abl, we screened a proteomic mRNA-proteinduced into the random region either upstream (62) or
downstream (4) of the fixed residue (Figure 3B). Of the library derived from human bone marrow cells. A cellular
mRNA-protein fusion library was constructed by ran-21 clones in which the invariant tyrosine was not part of
a consensus sequence, 11 contained a second tyrosine domly priming cellular mRNA to create a mixture of full-
length and partial cDNA fragments. A random primingthat did match the I/L/V-Y-X1-5-P/F consensus. In the
majority of clones, an upstream tyrosine was introduced approach was used in order to minimize the presence
of translational stop codons that prevent mRNA-proteineither three (13/62) or four (45/62) residues upstream
of the fixed tyrosine. Only 3/13 clones containing the fusion formation. Following in vitro translation and fu-
sion, a proteomic library was generated in which mosttyrosine (y) at position n3 relative to the fixed residue
(Y) (y-X-I/L/V-Y) conformed to the consensus phosphor- cellular proteins were expected to be represented in
sizes ranging from epitope size to full length. Cellularylation sequence. This result is not surprising given the
requirement for a hydrophobic residue upstream of the targets of v-abl were selected from this library following
phosphorylation by v-abl and immunoprecipitation withinvariant tyrosine. In contrast, if the tyrosine (y) was
present at n  4, almost half the clones matched the the 4G10 antibody. Repeated rounds of selection pro-
duced an enriched pool of v-abl cellular substrates.consensus sequence (23/45). All of the clones con-
taining an additional tyrosine immediately upstream of
the fixed residue (n  1) or at positions n  2 or Enrichment of mRNA-Protein Fusions Containing
n  5 matched the v-abl kinase consensus motif with Phosphorylated Tyrosines
respect to either the novel or invariant tyrosine. Only 11 Approximately 1 pmol of the starting mRNA-protein li-
clones were either missing a tyrosine or contained one brary was used in the first round of the proteomic selec-
that did not match an obvious phosphorylation consen- tion. In order to minimize the loss of genetic diversity,
sus motif (Figure 3C). the preclear step was again omitted in the first round
In summary, 58/69 clones contained a tyrosine within of the selection. The first two rounds of the selection did
the I/L/V-Y-X1-5-P/F consensus motif. The v-abl kinase not yield detectable radioactive counts in the elutions;
phosphorylated all of the clones (12/12) representing although, PCR yielded genetic material that was taken
the various classes of consensus motifs that were tested to the next round (data not shown). In contrast, approxi-
(data not shown). These results demonstrate the enrich- mately 2% of the input mRNA-protein fusion molecules
ment of v-abl substrates from the randomized peptide were eluted (E1 E2) from the 4G10 antibody in round
library and suggest that v-abl can potentially phosphory- three, and this increased to 6% in rounds four and five.
late a wider range of peptide substrates than previously The percentage of input mRNA-protein fusion molecules
thought. eluted in rounds four and five was significantly greater
than that in wash five (W5) and was similar to that recov-
ered using the optimal v-abl target (see above). In addi-Selection of Cellular Proteins Phosphorylated
by v-abl tion, PCR analysis demonstrated that the last wash of
round five (W5) was devoid of mRNA-protein fusion mol-Peptide substrates of v-abl were successfully selected
from a randomized mRNA-peptide fusion library follow- ecules (data not shown). Together these results demon-
strate that substrates of v-abl were enriched from theing six rounds of selection. However, our results demon-
strated that v-abl can phosphorylate a broad consensus cellular mRNA-protein library following five rounds of
selection and PCR amplification of genetic material.sequence, making it difficult to identify potential cellular
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ylation sites were also detected in the hybridization anal-
ysis. In most cases, these correspond to proteins known
to interact with v-abl, or proteins that are involved in
cellular processes affected by v-abl [23, 26, 27].
The potential v-abl phosphorylation sites identified in
the filter analysis were very similar to the v-abl consen-
sus sequence identified from the selection of a random-
ized peptide library. Nevertheless, to examine the nature
of the enriched pools more precisely, the pools from
rounds four and five of the selection were subcloned,
and the resulting clones were sequenced. Sequence
analysis of 102 clones indicated that the v-abl target
clones could be divided into the following three major
groups: clones fitting the kinase consensus sequence
I/L/V-Y-X1-5-P/F (64/102), those lacking a downstream
proline/phenylalanine residue (14/102), and those lack-
ing an upstream hydrophobic residue (14/102). Only a
small fraction of the clones (10/102) had more than one
difference from the consensus sequence or no tyrosine.
To determine whether members of the three classes
could serve as v-abl substrates, representative clones
were expressed individually as free peptides and tested
for v-abl phosphorylation in vitro (data not shown). As
summarized in Figure 4C, clones representing all three
groups were phosphorylated. Only 3 of the 13 clonesFigure 2. Enrichment of v-abl Substrates from a Randomized Pep-
tested in the individual kinase assays were not phos-tide Library
phorylated by v-abl. These sequences closely matched(A) Elution profiles of a randomized peptide library displayed as
mRNA-peptide fusions following six rounds of v-abl phosphorylation the v-abl consensus sequence, and failure to detect
and 4G10 immunoprecipitation. The percent elution was based on phosphorylation might be due to the close proximity of
the input of mRNA-peptide fusion molecules labeled with [35S]methi- the tyrosines to the FLAG epitope and the antibody used
onine. In round one, the library was not precleared prior to phosphor- to immunoprecipitate the free proteins. Together these
ylation with v-abl.
results demonstrate that cellular substrates of v-abl can(B) Enrichment of v-abl substrates from a randomized peptide library
be selected from a cellular mRNA-protein fusion libraryfollowing six rounds of selection. DNA from the starting library (lane
3) and the post-round six elution (lane 4) was transcribed by T7 and that the repertoire of potential v-abl targets is much
polymerase, translated in the absence of radiolabeled methionine, broader than indicated by previous studies.
and immunoprecipitated with FLAG protein A Sepharose beads. Homology searches using the sequenced clones iden-
In the kinase reactions, immunoprecipitates were phosphorylated tified 13 known genes and 3 predicted ORFs. One of
with v-abl in the presence of [-32P]ATP, washed extensively, and
the known genes was identified as actin, previously pub-then resolved on a 4%–20% Tris-glycine gel. As a control for immu-
lished as a v-abl-interacting protein [36, 37]. The transla-noprecipitation, parallel in vitro translation reactions were done in
the presence of [35S]methionine. The B43 clone is a negative control tion elongation factor elF-4AIII was found twice, and
for the kinase reaction (lane 2) and contains a single tyrosine residue the selected clone is phosphorylated by v-abl in vitro.
in the FLAG epitope (DYKDDDDK), while the C23 clone serves as Nebulin was found 31 times, and cytochrome C oxidase
the positive control (lane 1) and contains the known v-abl phosphor- subunit 3 was found 25 times. A total of 33 clones
ylation sequence (IYAAP).
showed no homology to any genes in the GenBank data-
base. Efforts are underway to characterize a subset of
Analysis of Selected Pools these targets and establishe their significance in v-abl
Since the starting mRNA-protein fusion library consists function.
of the full repertoire of proteins expressed in human Many of the nebulin and cytochrome C oxidase clones
bone marrow cells, the enrichment of desired clones contained different 5 or 3 termini, indicating that the
can be rapidly ascertained by hybridization to human clones arose from distinct priming events during con-
cDNA microarrays. As a first step in the analysis of the struction of the library. This suggests that, as expected,
selected pools, DNA from rounds four and five of overlapping protein domains are present in the mRNA-
the selection were hybridized to cDNA microarrays protein fusion library. Nebulin is closely associated with
containing 	18,000 EST clones, and the hybridization actin and may represent a novel substrate for v-abl given
intensities were compared to those obtained with the its high representation in the selected pools and its
starting (round zero) library (Figure 4A). The filter con- phosphorylation by v-abl in vitro. In contrast, the seg-
tained four known v-abl substrates, namely, Crk1 [29, ment of cytochrome C oxidase selected in this study is
30], the regulatory subunit (p85) of phosphoinositol-3- embedded inside the core of the full-length protein and
kinase [31], the Arg/Abl-interacting protein ArgBP2 [32], may not be accessible to v-abl in vivo.
and the JAK1 tyrosine kinase [33, 34], as well as the
large subunit of RNA polymerase II, a previously re- Shg Is a Novel SH2 Domain-Containing
ported target of c-abl [35]. All of these targets were Adaptor Protein
enriched during the selection procedure (Figure 4B). Nu- Sequence analysis indicated that one of the fragments
(TC26) obtained in round five of the selection (Rd5-26,merous other ESTs containing potential v-abl phosphor-
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Figure 3. Summary of the Sequences Obtained from the Randomized Peptide Selection Following Six Rounds of Selection
(A) Phosphorylation consensus sequences with respect to the fixed tyrosine residue. Amino acids immediately surrounding the randomized
sequences are shown. The number of sequences in each category is indicated within the brackets. A total of 11 sequences fall into more
than one category.
(B) Phosphorylation consensus sequences with respect to additional tyrosine residues introduced within the randomized region by the
selection. The number of clones in each category is indicated directly adjacent to the consensus sequence. The number of sequences within
each category in which the novel tyrosine is part of the I/L/V-Y-X1-5-P/F consensus sequence is italicized. Six sequences fall into more than
one category.
(C) Sequences either lacking a tyrosine or an obvious v-abl phosphorylation motif.
Figure 4C) had homology to a class of SH2 domain (Src sought to determine whether v-abl substrates selected
from the random peptide and proteomic libraries couldhomology 2)-containing adaptor proteins (Figure 5A).
Two members of this family, Shc and Shd, are phosphor- inhibit kinase activity if the target tyrosine was mutated
to phenylalanine. One of the mutagenized peptidesylated by v-abl in vivo [38, 39]. TC26 contains four poten-
tial v-abl phosphorylation sites. Experiments using mu- (m-M16) inhibited v-abl activity at 50 M (Figures 6A
and 6B), while three additional peptides (mRd6-21,tagenized peptides demonstrated that only the first
tyrosine is a substrate for v-abl (Figures 5B and 5C). m-B47, and mT13) were effective inhibitors at concen-
trations of 500 M. In marked contrast, a phenylalanineBecause this family of proteins appears to be important
for abl function, a PCR-based strategy was used to substitution in an optimized v-abl target sequence de-
rived from selections of a randomized peptide libraryobtain sequence information for the full-length shg clone
(Figure 5D). The Shg protein has a predicted molecular (v-abl-mut) [28] was less effective as a kinase inhibitor,
weight of 54 kDa (495 aa) and is relatively basic (pI  further underlying the observation that distal amino
9.2). Similar to other members of the family, Shg contains acids are important determinants of catalytic specificity.
an SH2 domain near its carboxyl terminus (393–477). The A subset of control peptides (r series) containing the
amino termini of all known family members are highly same amino acids as the test peptides, but in a scram-
divergent; however, Shg is unique in that it contains bled order, did not have a significant effect on v-abl
an N-terminal myristylation site, which could serve to kinase activity.
anchor this cytosolic protein to the cell membrane. Ex-
periments to confirm the phosphorylation of Shg by
v-abl in vivo and to elucidate the biological function of Discussion
this interesting protein are in progress.
A randomized peptide library and a cellular protein li-
brary derived from the mRNA of human bone marrowInhibition of v-abl Kinase Activity
cells were displayed as mRNA-protein fusions. Sub-In addition to the information gained by the identification
strates of v-abl were selected from these libraries follow-of novel kinase targets, common sequence motifs
ing successive rounds of enrichment. Selections fromacross selected targets allow for a focused interrogation
the randomized peptide library identified a consensusof potential active site inhibitors. The activity of several
sequence for v-abl phosphorylation, which closelyserine/threonine kinases has been inhibited using kinase
matched that reported previously. Selections from thepseudosubstrates in which the target serine has been
proteomic library derived from cellular mRNA identifiedmutated to an alanine [40–42]. In an analogous manner,
numerous proteins previously reported to be substratesthe tyrosine kinase activity of ZAP-70 was inhibited by
of v-abl in vivo. In addition, several novel potential tar-a pseudosubstrate containing a tyrosine-to-phenylala-
nine substitution mutation [43]. Consequently, we gets of v-abl were also selected, including a previously
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Figure 4. Analysis of Clones Obtained from Round Four or Five of the Selection for Cellular Targets of v-abl
(A) Hybridization of radiolabeled DNA from round zero or round four to a cDNA microarray filter. Hybridization of the pools to one of the filter’s
six grids is shown. Examples of increased signals following hybridization of the round four pool relative to the round zero pool are indicated.
(B) Clones identified by the DNA microarray analysis as targets of v-abl kinase. The first five clones are published targets of v-abl. A subset
of ESTs showing increased signals following hybridization of the round four DNA pool that contains potential v-abl phosphorylation sites is
shown.
(C) A subset of genes identified by sequence analysis following round four (Rd4) or five (Rd5) of the v-abl selection. Parent gene identities
were determined based on BLAST homology searches. Relevant tyrosine residues and surrounding amino acids are underlined and in bold
type. The first clone has been reported to bind to v-abl.
unidentified protein that is homologus to a family of SH2 sequence combinations having the desired phenotype.
This allows for structure-function analysis of the kinasedomain adaptor proteins.
Identification of kinase substrates from synthetic ran- active site and the efficient development of kinase in-
hibitors. Selections from a randomized peptide librarydom peptide libraries allows for the survey of all possible
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Figure 5. Sequence Analysis of Shg, a Novel
Member of a Class of SH2 Domain-Con-
taining Adaptor Proteins
(A) Sequence comparison between TC26 and
other members of the SH2 domain adaptor
protein family for which full-length sequences
are published. Potential v-abl phosphoryla-
tion sites are indicated.
(B) Peptides used to map the tyrosine residue
phosphorylated by v-abl.
(C) v-abl phosphorylates the first tyrosine of
the TC26 clone. Phosphorylation reactions
were done in the presence of recombinant
v-abl and trace amounts of [-32P]ATP in the
absence () of kinase substrate, using a com-
mercially available v-abl target peptide () as
the substrate or one of the peptides shown
in (B) as the substrate.
(D) The amino acid sequence of the full-length
Shg clone. The original sequence obtained
following five rounds of selection is boxed,
with the tyrosine substrate of v-abl underlined
and in bold. A putative myristylation site and
an SH2 domain are indicated by a dashed
and solid underline, respectively. The asterisk
denotes the stop codon.
displayed as mRNA-peptide fusions identified I/L/V-Y- Most clones selected as v-abl targets from the cellular
mRNA-protein library contained sequences closelyX1-5-P/F as a target sequence for v-abl phosphorylation.
Although n 4 or 5 were preferred, more proximal posi- matching the consensus sequence identified from the
randomized peptide library. Cellular mRNA-protein li-tioning of the P/F residues was tolerated. This sequence
is similar to the I/L/V-Y-X3-4-P/F consensus identified braries offer several advantages for the identification of
novel kinase-substrate interactions. First, since they arepreviously. Differences in the scaffold sequences sur-
rounding the randomized region, the larger size of the derived from cellular mRNA, they reflect the cell’s pro-
teome and therefore consist of a pool of biologicallylibrary assayed (1013 members), and the incorporation
of all possible amino acids in the synthesis of the ran- relevant targets. Second, since the libraries are of cellu-
lar origin, clones enriched during the selection can bedomized segments may account for slight differences
in the consensus sequences. In addition, the use of efficiently analyzed by hybridization to cDNA microarray
filters analogous to the methods used to quantify cellularPCR to amplify genetic material encoding the desired
phenotype allowed for a sensitive determination of sub- transcript levels. Third, the relatively limited number of
mRNAs in a cell, coupled with the large size of the library,strate specificity. Interestingly, many of the selected
peptides contained more than one tyrosine. In some allows for multiple representation of each protein in the
starting library. And, finally, because a random primingcases, the novel tyrosine was not part of the consensus
sequence, and, therefore, its presence may not be sig- approach is used during cDNA synthesis of the mRNA-
protein fusion library, minimal interacting domains ofnificant. However, in other cases, dual phosphorylation
of the tyrosine residues may have aided in selection interest can be mapped from overlapping clones en-
riched during the selection.of the target. The presence of cysteines flanking the
randomized region allows for the possibility that the Numerous substrates identified from the cellular
mRNA-protein selection are closely associated with pro-randomized peptides can be exhibited as part of a con-
strained surface loop during the selection. Although im- teins previously identified as ligands or substrates of
v-abl. For example, nebulin is a skeletal protein closelypossible to rule out, we believe that this is rather unlikely
given the presence of DTT in the v-abl kinase reaction associated with actin [37, 44]. Significantly, nebulin also
contains an SH3 domain, a motif present in other abl-and the absence of cysteine residues in the selected
clones. interacting proteins such as Grb-2, Nck, and Crk v-abl
Chemistry & Biology
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Figure 6. Tyrosine-to-Phenylalanine Muta-
tions Can Convert Cellular Targets of v-abl to
Kinase Inhibitors
(A) Sequences of the phenylalanine deriva-
tives tested for inhibition of v-abl kinase activ-
ity. Mutagenized test peptides (m series) as
well as the scrambled controls (r series) are
shown. Relative v-abl activity was scored as:
90%–100% (), 50%–90% (), 10%–50%
(). A subset of control peptides (r series)
containing the same amino acids as the test
peptides, but in a scrambled order, did not
have a significant effect on v-abl kinase ac-
tivity.
(B) Examples of kinase inhibition assays. Mu-
tagenized peptides were added to kinase re-
actions containing an optimized v-abl sub-
strate at a 100:1, 10:1, or 1:1 molar ratio
relative to the target peptide. Kinase reac-
tions in the absence of an inhibitory peptide
() were done for comparison.
[29]. The high representation of nebulin in the selected in our experiments suggests that these proteins might
also serve as substrates of c-abl. In addition to substratepools, and the ability of v-abl to phosphorylate nebulin
in vitro, suggests that this protein may play a biological sequences at the site of catalysis, kinase specificity is
also determined by cellular localization and the interac-role in v-abl function. Interestingly, Filamin A [45] and
another actin binding protein associated with the SWI/ tion of the kinase with adaptor proteins or domains [2].
All these factors must be considered when evaluatingSNF complex [46] were also enriched in these experi-
ments. In addition, we also selected for the Grb2-associ- the biological relevance of protein domains identified
during the selection.ated binding protein Gab1 [47]. Grb2 has previously
been reported to interact with v-abl, c-abl, and BCR- We have obtained the full-length sequence of Shg,
a novel member of a class of SH2 domain-containingabl [23]. It may be significant that Gab1 can serve as a
docking site for several SH2-containing proteins and adaptor proteins that consists of the proteins Shb, Shc,
Shd, She, and Shf. Shb functions in T cell receptor sig-that it contains numerous possible tyrosine phosphory-
lation sites. naling and binds to the SH3 domain of Grb2 via its
proline-rich motif [48, 49], while the SH2 domain of ShcC-abl is both a nuclear and cytosolic protein and has
been shown to bind to DNA and to phosphorylate the is believed to mediate the function of the epidermal
growth factor receptor (EGFR) function through its inter-carboxyl-terminal domain (CTD) of the large subunit
(RPB1) of RNA polymerase II [35]. In contrast, v-abl is action with an unidentified protein [50]. Shd and She
were originally identified in a yeast two-hybrid screenfound only in the cytoplasm, and therefore nuclear pro-
teins are unlikely to serve as biological substrates. Nev- using the c-abl kinase domain as the bait [38], while Shf
was cloned by searching the GenBank database forertheless, v-abl and c-abl share significant regions of
homology. Therefore, the selection of the RPB2 subunit proteins homologous to Shb [51]. Although Shc and Shd
are substrates of v-abl in vivo, the roles they play in theof RNA polymerase II and the translation factor elF-4AIII
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abl signaling pathways are unclear. The presence of tional subcloning and transformation of libraries into
host cells. In addition to querying enzyme-substratea serine-rich domain and a myristylation site in Shg
suggests a unique role for this protein in abl function. interactions, cellular mRNA-protein libraries have also
been used recently to identify protein-protein and pro-In addition to the residues immediately surrounding
the target tyrosine, more distal amino acids clearly play tein-drug interactions. When used in conjunction with
protein structural studies and transcript profiling, cel-a role in the presentation of the target to the kinase
active site. Consequently, a subset of v-abl peptides lular mRNA-protein libraries will be an important tool
in deciphering the network of cellular protein interac-and cellular targets identified in this study were modified
by a tyrosine-to-phenylalanine mutation and tested for tions.
their ability to inhibit v-abl kinase activity in vitro. Four
of the 13 peptides tested inhibited v-abl kinase activity. Experimental Procedures
The ability of these peptides to inhibit kinase activity in
vivo is being tested. Construction of mRNA-Protein Fusion Libraries
Randomized Peptide LibraryTogether these experiments demonstrate that tyro-
Approximately 1.2 nmol of the gel-purified Abl-2NNS oligo (5-sine kinase substrate sequences can be selected from
GGCGAGGAGGGATGTGGAGGANNS5TACNNS5GGATGTGGAGACsynthetic mRNA-protein fusion libraries as well as from
TACAAGGACGAG-3), encoding the amino acid sequence 5-GEEGproteomic libraries derived from cellular mRNA. As a
CGGX5YX5GCGDYKDE-3, was amplified by PCR (3.5 ml) using theuniversal tool for proteomic applications, the cellular f-Abl-NNS primer (5-TAATACGACTCACTATAGGGACAATTACTAT
mRNA-protein fusion libraries offer a tremendous re- TTACAATTACAATGGTGAGCAAGGGCGAGGAGGGATGTGGAGG-3)
and the r-Abl-NNS primer (5-AGCTTTTGGCTCGTCCTTGTAGTCsource. The robustness of the mRNA-protein covalent
TCC-3). The forward primer was designed to incorporate se-bond, and the fact that library production and selection
quences required for in vitro transcription and translation, while theoccur entirely in vitro, makes this approach ideally suited
reverse primer was used to add sequences needed for RNA-DNAfor multiple purposes. This includes the identification of
ligation and fusion production. The library was amplified through
protein-protein [52] and protein-drug (M. McPherson et five cycles of PCR in a microtiter plate containing Ready-To-Go
al., personal communication) interactions in addition to PCR beads (Amersham Pharmacia) at the following conditions: 95
C
for 1 min, 65
C for 2 min, and 72
C for 1 min, followed by a 5-minsubstrates undergoing posttranslational modifications.
extension step at 72
C. PCR products were extracted with phenol/When used in conjunction with protein structural infor-
chloroform/iso-amyl alcohol, concentrated by ethanol precipitation,mation, protein localization data, and gene expression
and transcribed using the T7 polymerase MEGAshortscript in vitroprofiling, this technology will provide a critical element
transcription kit (Ambion). Following treatment with DNase, the RNA
for the postgenomic analysis of the proteome. was phenol extracted, purified on a NAP 25 column (Amersham
Pharmacia), and concentrated by isopropanol precipitation. Purified
RNA was ligated to a DNA-puromycin linker (p-dA28CCPu) using
the SPL-PKA oligo (5-TTTTTTTTTTNAGCTTTTGGCTCGTC-3) as aSignificance
splint between the 3 terminus of the RNA and the 5 terminus of
the puromycin linker. The RNA, DNA-puromycin linker, and splintTyrosine kinases play a critical role in numerous bio-
(35 nmol each) were heated to 70
C for 3 min and incubated at roomlogical processes including the response of cells to
temperature prior to the addition of 10 ligation buffer and T4 ligase
changing environmental conditions. Identification of (Promega). The ligation mixture was resolved on a polyacrylamide-
kinase substrates is a critical step toward understand- urea denaturing gel (NOVEX), and the ligated product was eluted
(200 mM NaCl, 10 mM Tris [pH 7.4], 1 mM EDTA). Following ethanoling the cellular function of kinases. Here, we employ
precipitation, 1 nmol ligated RNA was added to a 1.8 ml Retic lysatea display technology in which proteins are covalently
IVT translation reaction (Ambion) containing rabbit reticulocyte ly-linked to their encoding mRNA via a puromycin linker
sate and [35S]methionine. Following incubation at 30
C for 30 min,(mRNA-protein fusion) to identify v-abl tyrosine kinase
mRNA-protein fusion was promoted by the addition of KCl and
substrates from a large (1012–1013) synthetic peptide Mg2Cl (final concentrations of 500 mM and 150 mM, respectively)
library. In addition, a library in which the proteome of and incubation at 25
C for 1 hr. mRNA-protein fusion molecules
were purified from the in vitro translation mix by oligo d(T) chroma-human bone marrow cells is represented as mRNA-
tography by virtue of the poly A sequence in the DNA-puromycinprotein fusions was synthesized and screened for cel-
linker. Briefly, the translation-fusion mix was diluted 10-fold in coldlular targets of v-abl. Several known targets of v-abl
(4
C) oligo d(T) binding buffer (100 mM Tris-HCl [pH 8.0], 1 M NaCl,were identified, as well as novel targets including a
0.25% Triton X-100, 10 mM EDTA) and bound to equilibrated oligo
new member of a class of SH2 domain-containing d(T) resin (Amersham Pharmacia) in a batch format. The oligo d(T)
adaptor proteins. The identification of v-abl targets slurry was transferred to a column, and the bed was washed exten-
sively with binding buffer lacking EDTA (4
C). mRNA-protein fusionsfrom both libraries led to the rapid development of
were eluted in water (25
C) and quantified by scintillation counting.peptides that inhibit v-abl kinase activity in vitro. Pro-
cDNA synthesis from the fusion library (50 pmol) was done usingteomic mRNA-protein libraries provide an important
the r-Abl-NNS primer and SUPERSCRIPT II RNase H Reverse Tran-tool for the identification of cellular protein-protein
scriptase (GIBCO-BRL Life Technologies) as suggested by the man-
interactions. In addition to determining the substrates ufacturer. Approximately 25 pmol of the starting library was used
of tyrosine kinases, cellular libraries can also be used in the first round of the selection.
Cellular mRNA-Protein Libraryto identify a variety of other enzyme-substrate interac-
Poly-A mRNA from human bone marrow (Clontech) was primedtions, since the in vitro nature of the selection cycle
using the R-HBM1 oligonucleotide 5-GCCTTATCGTCATCGTCCTallows for reaction conditions to be optimized and
TGTAGTCGAAACTAGAN9-3, and cDNA was synthesized usingeliminates nonspecific protein modification(s) during
SUPERSCRIPT II RT (Promega). After RNase H treatment, unex-
propagation in the host cell. Furthermore, the in vitro tended primer was removed by purification over an S-300 (Amer-
construction of the libraries minimizes the loss of ge- sham Pharmacia) size exclusion column equilibrated in TE (10 mM
Tris-HCl [pH 8.0], 1 mM EDTA). Second strand cDNA synthesis bynetic information normally associated with conven-
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the Klenow fragment of E. coli DNA polymerase was primed using Exceptionally, [-32P]ATP was added to the kinase reaction in round
one of the cellular selection to facilitate the detection of the fusions.the F-HBM2 oligonucleotide 5-GGACAATTACTATTTACAATTA
CAATGN9-3. Unextended primers were again removed using a
S-300 column, and the cDNA products were amplified by PCR using
Analysis of cDNA Microarraysthe primer pairs 5-TAATACGACTCACTATAGGGACAATTACTATT
Pool PCR products were labeled by random priming using the Redi-TACAATT-3 (T7TMVUTR) and 5-AGAAGATGCGCGATCGTCATCG
prime DNA labeling system (Amersham Pharmacia) and [-33P]dCTPTCCTTGTAGTC-3 (FLAGRASS). Taq polymerase (Promega) was
(2000–4000 Ci/mmol). Unincorporated [-33P]dCTP was removed byadded to PCR reactions (1.2 ml) after an initial 5-min denaturation
chromatography, and labeled DNA was hybridized to the filters (Ge-step at 95
C. An annealing temperature of 44
C (2 min) was used
nomeSystems) as described by the manufacturer. Hybridization sig-in the first four rounds of the PCR reaction, followed by 65
C in
nals were visualized by phosphorimager analysis, and the relativethe subsequent rounds (20–30 cycles). Denaturation and extension
intensities were determined using the manufacturer’s Genome Dis-steps were done at 95
C (1 min) and 72
C (2 min), respectively,
covery Software (GDS).followed by a final 10-min extension step at 72
C. PCR products
were concentrated using the QIAquick PCR purification kit (Qiagen)
and fractionated on an S-300 Sephadex column. DNA from the first Kinase Assays
two fractions (500 l) was ethanol precipitated. RNA (5 nmol) was Phosphorylation of the mRNA-protein fusion library by v-abl was
synthesized using the T7 polymerase MEGAscript in vitro transcrip- done as described above. To test individual clones for phosphoryla-
tion kit (Ambion) according to the manufacturer’s suggestions. RNA tion by v-abl, unligated RNA (50 pmol) was in vitro translated in
(3 nmol) was ligated to 4.5 nmol of the p-dA28CCPu puromycin the absence of [35S]methionine. FLAG-tagged peptides were immu-
linker using the biotinylated SPLINTRASS oligo (4.5 nmol, 5- noprecipitated with M2-FLAG agarose beads (Sigma) and equili-
B2B1GCAACGACCAACTTTTTTTTTN-3) as the splint. The RNA, brated in v-abl kinase buffer. Phosphorylation reactions were done
DNA-puromycin linker, and splint were heated to 80
C for 10 min in the presence of [-32P]ATP essentially as suggested by the manu-
and then cooled to 20
C (0.1
C/min) prior to the addition of 10 facturer. Free [-32P]ATP was removed by washing the beads in
ligation buffer and T4 ligase (Promega). Reactions were incubated kinase buffer. Phosphorylated products were resolved on a 4%–
at 20
C overnight, and then diluted to 1 ml in PBS buffer. Neutra- 12% BIS-Tris gel with MES as the running buffer and visualized by
Avidin beads (Pierce) were added (600 l) to the mixture and incu- the STORM 860 phosphorimaging system (Molecular Dynamics). To
bated for 1 hr at 30
C. The beads were washed three times in confirm the immunoprecipitation of the desired peptides, parallel
prewarmed PBS (30
C). Ligated RNA was dissociated from the bio- immunoprecipitations were done using peptides labeled with
tinylated splint by resuspending the Neutra-Avidin beads in an equal [35S]methionine. Kinase inhibition assays contained 5 M of the
volume of water and incubating at 45
C for 15 min (repeated twice). commercial v-abl substrate (EAIYAAPFAKKK; New England Biolabs)
Approximately 200 pmol ligated RNA was recovered in a typical and increasing concentrations (5 M, 50 M, or 500 M) of the test
reaction. Following ethanol precipitation of the RNA, fusion produc- peptides. Peptides mRd6-21, mRd6-38, mRd6-45, mRd4-T5, Rd4-
tion and cDNA synthesis were done as described for the random T23, Rd4-B47, rRd4-B47, Rd4-M16, and the R5-TC26b series were
peptide library, except that the RT-RASS oligo (5-TTTTTTAGAA dissolved in a DMF (50%)-water (50%) solution (500 M). The re-
GATGCGCGATCGTCA-3) was used as the primer. The selection maining peptides were soluble in water.
was initiated with approximately 1 pmol of the library.
Cloning of Full-Length ShgSelection of mRNA-Protein Fusions Containing
A nested PCR strategy using gene-specific (TC26) and flankingPhosphorylated Tyrosines
adaptor primers was used to amplify the 3 and partial 5 shg se-Kinase substrates were selected from the random peptide and cellu-
quences from double-stranded cDNA prepared from human bonelar mRNA-protein fusion libraries using the same strategy. Typically,
marrow mRNA (Marathon-Ready cDNA, Clontech). Additional 5 shgPCR reactions (1.2 ml) were done using 1/10 the reaction volume
sequences were obtained by 5 RACE (GIBCO-BRL Life Technolo-of eluted DNA from the previous round of selection. Following syn-
gies) essentially as described by the manufacturer, except thatthesis of the mRNA-protein library, a typical round of selection in-
cDNA synthesis was done at 55
C and the terminal transferasevolved preclearing the library with 4G10/protein A Sepharose
reaction was done in the presence of dATP. Nested gene-specificbeads, phosphorylation of substrates with v-abl, immunoprecipita-
primers and appropriate flanking primers (3 RACE adaptor andtion of phosphotyrosines with the 4G10/protein A Sepharose
AUAP primers, GIBCO-BRL Life Technologies) were used to PCRbeads, and recovery of the attached genetic information by PCR.
the terminal 5 sequences of shg. PCR analysis using shg-specificBriefly, following cDNA synthesis (see Construction of mRNA-Pro-
flanking primers yielded a single 1.49-kbp band that hybridized totein Fusion Libraries), mRNA-protein libraries were diluted 10-fold
a transcript 1.5 kbp in size following hybridization to Northerninto 4G10 binding buffer (50 mM Tris-HCl [pH 7.6], 150 mM NaCl,
blots (data not shown).1% NP 40 and 1 mM EGTA, 10% glycerol, 1 mM Na3VO4, and 1 mM
NaF) and incubated with 20g 4G10 antibody (Upstate Biotechnol-
ogy) at 4
C for 2 hr. Preequilibrated protein A Sepharose beads (400
Sequence Analysis
l, 50% slurry; Amersham Pharmacia) were added to the immuno-
PCR products were cloned into pCR2.1-TOPO vector and trans-precipitation buffer, and incubation continued for 1 hr. The non-
formed into TOP10 cells as recommended by the manufacturer (In-bound void fraction was diluted 2-fold in oligo d(T) binding buffer
vitrogen). DNA was prepared using the Qiaprep Spin miniprep kitand purified on an oligo d(T) column as described previously. Peak
(Qiagen), and inserts were sequenced (DNA Sequencing Core Facil-fractions (10–20 pmol) were added directly to kinase reactions (3 hr
ity, Massachusetts General Hospital, Boston, MA). BLAST andat 30
C) containing recombinant v-abl (New England Biolabs) and
ClustalW60 were used to search the GenBank database and align100M ATP under conditions described by the manufacturer. Phos-
protein sequences, respectively.phorylated targets were immunoprecipitated using the 4G10 anti-
body and protein A Sepharose beads, and the beads were washed
five times with the immunoprecipitation buffer. Bound complexes Acknowledgments
and encoding cDNAs were eluted with 0.1 N KOH (4 100 l) and
neutralized with 1/10 volume of a 1 M Tris-HCl (pH 8.0) and acetic We wish to thank Laird Bloom, Stephen Hale, Markus Kurz, Peter
acid solution prior to PCR. RNA-protein fusion molecules were quan- Loshe, and Rick Wagner for helpful discussions and review of the
tified by scintillation counting in the presence of scintillation fluid. manuscript.
In round one of the randomized peptide and cellular selections, the
preclear step was omitted and the mRNA-protein fusion libraries
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